Page last updated: 2024-10-30

mesalamine and Infections, Helicobacter

mesalamine has been researched along with Infections, Helicobacter in 3 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"pylori."2.69Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. ( Duncan, HD; Green, JR; Pearce, CB; Timmis, L, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Grau, Mdel C1
Chaparro, M1
Díaz, R1
Gisbert, JP1
Piodi, LP1
Bardella, M1
Rocchia, C1
Cesana, BM1
Baldassarri, A1
Quatrini, M1
Pearce, CB1
Duncan, HD1
Timmis, L1
Green, JR1

Trials

1 trial available for mesalamine and Infections, Helicobacter

ArticleYear
Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Breath Tests; Colitis, Ulcera

2000

Other Studies

2 other studies available for mesalamine and Infections, Helicobacter

ArticleYear
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
    Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance;

2014
Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease.
    Journal of clinical gastroenterology, 2003, Volume: 36, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Female; He

2003